SMCI RAMSAY 2018: “Extracellular vesicles fom ME/CFS Patients and their effect on human mast cells and microglia mediators secretion”, Theoharides

Andy · Oct 10, 2018

Ramsay 2018 award recipient

“Extracellular vesicles fom ME/CFS Patients and their effect on human mast cells and microglia mediators secretion”

A project summary as written by Professor Theoharis Theoharides, MD, PhD

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects about 1-2% of the US population with a 4 to 1, female to male ratio, and is characterized by debilitating fatigue of six months in the absence of systemic diseases. Many ME/CFS patients also have Fibromyalgia Syndrome (FMS), Mast Cell Activation Syndrome (MCAS), Pelvic Bladder Syndrome/Interstitial Cystitis (PBS/IC) and Irritable Bowel Syndrome (IBS), which worsen with stress. Unfortunately, ME/CFS pathogenesis remains unknown and there are no objective biomarkers making accurate diagnosis, prognosis and effective treatment difficult.
Click to expand...

https://solvecfs.org/ramsay-2018-meet-professor-theoharis-theoharides-md-phd/

Dolphin · Oct 11, 2018

Log in or Sign up

SMCI RAMSAY 2018: “Extracellular vesicles fom ME/CFS Patients and their effect on human mast cells and microglia mediators secretion”, Theoharides

Andy Committee Member

Dolphin Senior Member (Voting Rights)

Share This Page

Log in or Sign up

SMCI RAMSAY 2018: “Extracellular vesicles fom ME/CFS Patients and their effect on human mast cells and microglia mediators secretion”, Theoharides

Andy Committee Member

Dolphin Senior Member (Voting Rights)

Share This Page

Useful Searches